LBC
GILD icon

Leigh Baldwin & Co’s Gilead Sciences GILD Stock Holding History

Leigh Baldwin & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
4,769
+1
+0% +$132 0.32% 68
2026
Q1 		$664K Buy
4,768
+2
+0% +$280 0.43% 54
2025
Q4 		$585K Buy
4,766
+2
+0% +$243 0.38% 63
2025
Q3 		$529K Buy
4,764
+101
+2% +$11.5K 0.3% 81
2025
Q2 		$517K Buy
+4,663
New +$496K 0.34% 79
2025
Q1 		– Sell
-4,660
Closed -$430K – 174
2024
Q4 		$430K Buy
+4,660
New +$420K 0.36% 80

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Leigh Baldwin & Co's GILD Position: Q2 2026 in Review

Leigh Baldwin & Co increased its Gilead Sciences (GILD) stake by 0.02% in Q2 2026, buying an estimated $132 and bringing the position to 4,769 shares worth $603K. The position accounts for 0.32% of the portfolio, ranked #68.

Leigh Baldwin & Co first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $664K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Leigh Baldwin & Co held 4,769 shares of Gilead Sciences worth $603K as of Q2 2026.
  • Leigh Baldwin & Co bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.32% of Leigh Baldwin & Co's portfolio in Q2 2026, its #68 holding.
  • Leigh Baldwin & Co first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Leigh Baldwin & Co's Gilead Sciences position peaked at $664K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.